CROS DE Included in German Biotech Report

Aug. 4, 2011 - PRLog -- CROS DE, a wholly-owned German     subsidiary of CROS NT, has been included in the “Cluster Biotechnology Bavaria”   survey and report released this week. The survey consisted of small and medium-sized Contract Research Organisations (CRO), pharma and biotech companies which have an office located in the Bavaria region of Germany.

Since 2009, there are 13 newly established entities in the Munich area. In total, there are approximately 129 small to medium-sized biotech companies in Bavaria which incliudes 61 CROs. CROS DE is one of the newly established CROs in the region, having opened its Augsburg office in 2010.

CROS DE GmbH is included in the company profile section of the report alongside pharma and     biotech powerhouses like Amgen, Astellas and Pfizer. The German subsidiary offers data management and statistical services and experience and expertise in Oncology, Dermatology and Respiratory therapeutic areas. CROS NT’s Vice President, Frank Freischläger, Chief Operating   Officer, Thomas Zwingers and Business Development Manager, Gudrun Skiba, are all based in Germany.

Related Links:
http://www.bio-m.org/fileadmin/user_upload/Publikationen/...

# # #

CROS DE is the wholly-owned subsidiary of CROS NT. The company is specialised in providing statistical and data mangement services to the pharmaceutical industry. With a highly qualified and experienced management team, CROS DE also brings expertise in oncology and dermatology-related research. CROS NT is a global functional service CRO with expertise in biostatistics completing over 800 projects.